Skip to main content
. 2015 Dec;24(138):621–629. doi: 10.1183/16000617.0063-2015

FIGURE 1.

FIGURE 1

Effect of pulmonary arterial hypertension (PAH) on SF-36-measured health-related quality of life (HRQoL) measures versus the normal population and other disease conditions [12–15]. COPD: chronic obstructive pulmonary disease; SF-36: Medical Outcomes Study 36-item short form.